Valuation: PharmaEssentia Corporation

Market Cap 62TCr 1.94TCr 1.68TCr 1.58TCr 1.43TCr 2.7TCr 1,85800Cr 2.74TCr 18TCr 7.22TCr 93TCr 7.29TCr 7.14TCr 3,09200Cr P/E 2026 *
60.4x
P/E 2027 * 38.6x
Enterprise Value 60TCr 1.86TCr 1.61TCr 1.51TCr 1.37TCr 2.58TCr 1,77900Cr 2.62TCr 18TCr 6.92TCr 89TCr 6.98TCr 6.83TCr 2,96000Cr EV / Sales 2026 *
21.4x
EV / Sales 2027 * 15.8x
Free-Float
68.31%
Yield 2026 *
0.06%
Yield 2027 * 0.1%
1 day+4.44%
1 week+22.40%
Current month+43.29%
1 month+25.67%
3 months+110.36%
6 months+126.83%
Current year+247.80%
1 week 41.2
Extreme 41.2
47
1 month 31.6
Extreme 31.6
47
Current year 14.05
Extreme 14.054054
47
1 year 13.06
Extreme 13.063063
47
3 years 8.49
Extreme 8.49009
47
5 years 7.97
Extreme 7.973873
47
10 years 7.97
Extreme 7.973873
47
Manager TitleAgeSince
Chief Executive Officer - 01/01/2017
Director of Finance/CFO - 14/10/2015
President - 25/06/2015
Director TitleAgeSince
Director/Board Member - 09/05/2000
Chairman - 24/09/2012
Director/Board Member - 29/05/2015
Change 5-day change 1-year change 3-year change Capi.($)
+4.44%+22.40% - - 1.94TCr
-1.90%+2.85%+61.37%+102.88% 7.01TCr
-3.21%-4.32%+31.19%+59.75% 5.29TCr
-2.05%-5.61%-3.14%+454.89% 2.7TCr
-1.27%-1.57%+46.46%+6.09% 2.36TCr
+1.05%-0.62%-17.40%-13.36% 2.34TCr
+0.10%+1.40%+38.98%-20.04% 1.87TCr
+3.81%+20.97%+263.48%+552.47% 1.94TCr
-0.95%-3.52%+20.04%+613.01% 1.59TCr
+1.24%-5.23%+33.19%+138.21% 1.27TCr
Average +0.13%+1.95%+52.69%+210.43% 2.93TCr
Weighted average by Cap. -0.71%+0.55%+49.85%+168.09%

Financials

2026 *2027 *
Net sales 2.78TCr 87Cr 75Cr 70Cr 64Cr 120.4Cr 8.3TCr 122.38Cr 825.05Cr 322.59Cr 4.15TCr 325.74Cr 318.66Cr 14TCr 3.71TCr 115.88Cr 100.09Cr 94Cr 86Cr 160.81Cr 11TCr 163.46Cr 1.1TCr 430.87Cr 5.55TCr 435.07Cr 425.63Cr 18TCr
Net income 1.05TCr 33Cr 28Cr 27Cr 24Cr 45Cr 3.14TCr 46Cr 311.78Cr 121.9Cr 1.57TCr 123.09Cr 120.42Cr 5.22TCr 1.63TCr 51Cr 44Cr 41Cr 37Cr 70Cr 4.86TCr 72Cr 483.01Cr 188.85Cr 2.43TCr 190.7Cr 186.56Cr 8.08TCr
Net Debt -2.65TCr -83Cr -72Cr -67Cr -61Cr -115.04Cr -7.93TCr -116.94Cr -788.34Cr -308.23Cr -3.97TCr -311.24Cr -304.48Cr -13TCr -3.47TCr -108.54Cr -94Cr -88Cr -80Cr -150.62Cr -10TCr -153.1Cr -1.03TCr -403.56Cr -5.2TCr -407.5Cr -398.66Cr -17TCr
Logo PharmaEssentia Corporation
PharmaEssentia Corp is a Taiwan-based company mainly engaged in the research, development, production and sale of new drugs. The Company is engaged in the research and development of new drugs, which are used for treatment of hematology, such as meloproliferative neoplasms (MPN), neutropenia, anemia; infectious disease, such as hepatitis C and hepatitis B; dermatology, such as psoriasis, and neurology, such as multiple sclerosis, among others. The Company’s products include KX01, P1101, Polycythemia Vera (PV), PEG-GCSF, PEG-EPO and others. The Company distributes its products within domestic market and to overseas markets.
Employees
131
Date Price Change
14/26/14 $47.00 +4.44%
13/26/13 $45.00 +0.90%
12/26/12 $44.60 -1.33%
11/26/11 $45.20 +9.71%
10/26/10 $41.20 +7.29%
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
7
Last Close Price
1,500.00TWD
Average target price
1,216.34TWD
Spread / Average Target
-18.91%

Quarterly revenue - Rate of surprise